Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 19 May 2026
- Closes
- 25 Sept 2028, 23:59 UTC
- Value
- USD 22,000,000
- Reference
- RFA-ES-27-004
- Location
- United States
- Sector
- Healthcare & Pharma
Details
The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes Center leadership, data management, and training); translational research and engagement; and research support functions. The scope of the SRP Centers is taken directly from the Superfund Amendments and Reauthorization Act of 1986, which limits competition for this program to accredited institutes of higher education.Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. Eligibility: Based on 42 USC 9660(a)(3) eligible applicants are limited to accredited institutes of higher education. Eligible applicants are permitted under the law, and encouraged by NIEHS, to subcontract as appropriate with other organizations as necessary to conduct portions of the research. Examples of other organizations may include generators of hazardous wastes; persons involved in the detection, assessment, evaluation, and treatment of hazardous substances; owners and operators of facilities at which hazardous substances are located; and/or State and local governments. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Estimated total programme funding: USD 22000000
Expected number of awards: 10
CFDA number(s): 93.143
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 411 notices from National Institutes of Health, going back to May 2023 — 378 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 369 open Healthcare & Pharma tenders in United States. This one closes in 728 days.
More from this buyer
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)· closes 25 May
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)· closes 16 Nov
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)· closes 5 Nov
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)· closes 10 Nov
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)· closes 17 Apr
Similar Healthcare & Pharma tenders
- Bag, Medical Instrument — 25 each, NSN 6545016918890· closes 5 Oct
- Scanner, Acquisition, TH — 1 each, NSN 6520017024522· closes 5 Oct
- Ventilator, Volume, Port — 6 each, NSN 6515017029684· closes 5 Oct
- Comprehensive Medical Services -FDC Houston — General Health Care Services· closes 17 Nov
- 2027 Southern Hemisphere Influenza Vaccine — Drugs and Biologicals· closes 14 Oct
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- 西安交通大学医学院第一附属医院心理量表评估系统(心理ct)采购项目公开招标公告西安交通大学第一附属医院 · China
- 108 VideomanagementStädtisches Krankenhaus Kiel GmbH · Germany
- LOS 3 - 1.600 EA Katheter, arterielle Embolektomie, 5FBundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr · Germany
- arbeitsmedizinische Betreuung für die Kreisverwaltung CoesfeldKreis Coesfeld · Germany
- DFG Großgerät Koordinatenmessgerät mit Tomografieeinrichtung - Mikrofocus- ComputertomografRheinland-Pfälzische Technische Universität Kaiserslautern-Landau · Germany
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →